CHRM3 and neoplasm: The genetic silencing of CHRM3 reduced tumor growth by 50%, whereas radiotherapy paradoxically amplified neuron–tumor connectivity, a vulnerability exploited by combining radiation with AMPA receptor inhibition, which synergistically suppressed growth.